Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studiesC Lebbé, J S Weber, M Maio, et al.
Journal of Virology|March 21, 2014
HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytesDaria Brinzevich, George R Young, Robert Sebra, et al.
Tissue Antigens|August 25, 2000
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatmentG Frumento, S Franchello, G L Palmisano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 1998
Absorption, distribution, metabolism, and excretion of atevirdine in the ratM Chang, V K Sood, G J Wilson, et al.
ESMO Open|November 7, 2025
Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failureI P da Silva, L Zimmer, J-Y Blay, et al.
British Journal of Cancer|April 16, 2002
Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implicationsL Sigalotti, S Coral, M Altomonte, et al.
Human Gene Therapy|December 28, 1999
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cellsF Arienti, F Belli, F Napolitano, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1997
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerabilityF Belli, F Arienti, J Sulé-Suso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2023
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201A Necchi, D Pouessel, R Leibowitz, et al.
Gynecologic Oncology|July 14, 2022
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 studyD M O'Malley, G M Bariani, P A Cassier, et al.
Pageof 9